Umamaheswar Duvvuri Selected Research

Ligands

12/2021	Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.
10/2019	Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients.
12/2017	EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Umamaheswar Duvvuri Research Topics

Disease

57	Neoplasms (Cancer) 03/2024 - 11/2006
39	Squamous Cell Carcinoma of Head and Neck 02/2024 - 11/2013
22	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 07/2013
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2024 - 12/2004
4	Neoplasm Metastasis (Metastasis) 06/2022 - 12/2004
3	Deglutition Disorders (Dysphagia) 10/2022 - 01/2013
3	Hemorrhage 01/2021 - 01/2016
3	Thyroid Neoplasms (Thyroid Cancer) 04/2016 - 12/2013
2	Extranodal Extension 02/2024 - 01/2018
2	Lung Neoplasms (Lung Cancer) 02/2024 - 05/2015
2	Oropharyngeal Neoplasms 10/2022 - 12/2004
2	Postoperative Hemorrhage 01/2021 - 01/2017
2	Carcinogenesis 12/2017 - 08/2012
2	Sarcoma (Soft Tissue Sarcoma) 03/2017 - 12/2014
2	Laryngeal cleft 03/2017 - 09/2014
1	Lymphedema (Milroy Disease) 03/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2024
1	Melanoma (Melanoma, Malignant) 02/2024
1	Stomatitis 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Mucositis 12/2022
1	Dermatitis 01/2022
1	Inflammation (Inflammations) 12/2021
1	Bites and Stings (Sting) 10/2021
1	COVID-19 01/2020
1	Pneumoperitoneum 01/2020
1	Paresis (Hemiparesis) 01/2018
1	Paresthesia (Dysesthesia) 01/2018
1	Margins of Excision 01/2018
1	Facial Pain (Myofacial Pain) 01/2018

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2013
9	Cetuximab (Erbitux)FDA Link 05/2022 - 03/2015
8	Chloride Channels (Chloride Channel)IBA 06/2023 - 07/2012
6	Monoclonal AntibodiesIBA 05/2022 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2012
6	ErbB Receptors (EGF Receptor)IBA 10/2021 - 12/2012
5	PlatinumIBA 02/2024 - 01/2018
4	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 12/2019
3	LigandsIBA 12/2021 - 12/2017
3	RNA (Ribonucleic Acid)IBA 12/2021 - 11/2015
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 05/2015
2	Amino Acids FDA Link 07/2023 - 09/2014
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 10/2019
2	Messenger RNA (mRNA)IBA 10/2021 - 12/2019
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 06/2017
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 05/2015
1	Interferon Type IIBA 02/2024
1	ceralasertibIBA 02/2024
1	durvalumabIBA 02/2024
1	PolyaminesIBA 07/2023
1	IpilimumabIBA 01/2022
1	IodineIBA 01/2022
1	SteroidsIBA 01/2022
1	Neuropilin-1IBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	IACS-010759IBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	Caveolin 1IBA 10/2021
1	Fibronectins (Fibronectin)IBA 10/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	MTOR InhibitorsIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Semaphorins (Semaphorin)IBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2020
1	ficlatuzumabIBA 06/2020
1	CarcinogensIBA 01/2020
1	Environmental CarcinogensIBA 01/2020
1	CopperIBA 12/2019
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	Neuregulin-1 (Neuregulin 1)IBA 10/2019
1	AlpelisibIBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Antisense DNAIBA 10/2018
1	VTX-2337IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 12/2017
1	ClathrinIBA 12/2017

Therapy/Procedure

24	Therapeutics 03/2024 - 08/2012
12	Radiotherapy 02/2024 - 01/2013
7	Neck Dissection (Radical Neck Dissection) 03/2024 - 12/2004
4	Immunotherapy 02/2024 - 01/2021
4	Tonsillectomy 03/2017 - 12/2015
3	Drug Therapy (Chemotherapy) 02/2024 - 01/2022
3	Free Tissue Flaps 11/2023 - 02/2016
3	Ligation 01/2021 - 01/2016
3	Re-Irradiation 01/2016 - 07/2014
2	Robotic Surgical Procedures 03/2024 - 01/2016
2	Aftercare (After-Treatment) 12/2022 - 01/2017
2	Minimally Invasive Surgical Procedures 01/2020 - 05/2012
2	Chemoradiotherapy 01/2018 - 01/2018
2	Lasers (Laser) 01/2016 - 09/2013
2	Glossectomy 12/2015 - 11/2013
1	Salvage Therapy 03/2024
1	Neoadjuvant Therapy 01/2023
1	Low-Level Light Therapy (LLLT) 12/2022
1	Cautery 01/2020
1	Electrocoagulation (Electrocautery) 01/2020
1	Injections 10/2018
1	Anesthesia 01/2018